在患有严重喘的患者中,tiotropium的成本效益
Jefferson Antonio Buendía1,2, Diana Guerrero Patiño3
1Research Group in Pharmacology and Toxicology "INFARTO", Department of Pharmacology and Toxicology, University of Antioquia, Medellín, Colombia. jefferson.buendia@gmail.com.
Cost effectiveness and resource allocation : C/E
|January 18, 2024
概括
添加tiotropium到通常的喘护理对于那些在吸入性皮质类固醇和长效β-agonists上不受控制的患者来说是具有成本效益的. 这一策略提供了积极的净收益,改善了严重喘管理的结果.
科学领域:
- 肺部医学 肺部医学
- 卫生经济学 卫生经济学
背景情况:
- 严重的喘影响了显著的患者比例,尽管标准的吸入性皮质类固醇 (ICS) 和长效β-激动剂 (LABA) 治疗.
- 酸铁是一种推的补充疗法,用于患有无法控制的严重喘的患者.
研究的目的:
- 评估tiotropium作为哥伦比亚严重喘患者的附加治疗的成本效益.
- 为了比较tiotropium补充疗法的成本和质量调整寿命年 (QALYs) 与标准ICS/LABA治疗.
主要方法:
- 使用概率马尔科夫模型来评估严重喘患者的成本和QALY.
- 进行比较的干预措施是标准治疗 (ICS/LABA) 和附加tiotropium治疗.
- 在QALY的支付意愿值为5180美元时,分析了成本效益.
主要成果:
- 提奥补充治疗的增量成本效益比 (ICER) 估计为2637.59美元.
- 有77%的概率,tiotropium加上ICS/LABA比单独的ICS/LABA更具成本效益.
- 铁证明了最高预期的净收益,估值为800美元.
结论:
- 额外的tiotropium治疗对于中高剂量ICS/LABA无法控制的严重喘患者来说是一个具有成本效益的策略.
- 这些发现支持使用提奥来改善中等收入国家的临床实践指南.
- 建议在不同的环境中进一步复制以验证这些成本效益结果.
相关概念视频
01:26COPD: Management Using Bronchodilators and Corticosteroids
208
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
208
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
267
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
267
01:19Antiasthma Drugs: Leukotriene Modifiers
302
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
302
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:24Antiasthma Drugs: Methylxanthines
231
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
231
01:23Inhaled Medications
271
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
271